Antihistamine DTC Ads Demonstrate Suitability Of OTC Use, WellPoint Says
This article was originally published in The Tan Sheet
Executive Summary
Direct-to-consumer advertising of Rx antihistamines demonstrates that patients could readily self-diagnose and self-treat with the drugs in an OTC setting, WellPoint Health Networks VP Robert Seidman stated during an FDA switch advisory committee meeting.
You may also be interested in...
WellPoint Would Take A Mulligan On Antihistamine Petition In Hindsight
If it could do it all over again, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman said the insurer would use an alternate approach to requesting forced over-the-counter switches of certain classes of drugs through a FDA citizen petition
WellPoint Would Take A Mulligan On Antihistamine Petition In Hindsight
If it could do it all over again, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman said the insurer would use an alternate approach to requesting forced over-the-counter switches of certain classes of drugs through a FDA citizen petition
WellPoint Would Take A Mulligan On Antihistamine Petition In Hindsight
If it could do it all over again, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman said the insurer would use an alternate approach to requesting forced over-the-counter switches of certain classes of drugs through a FDA citizen petition